PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZIVO Bioscience, Inc. (ZIVO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US98978N2009

CUSIP

98978N200

Sector

Healthcare

IPO Date

Sep 24, 2012

Highlights

Market Cap

$71.02M

EPS (TTM)

-$4.83

Total Revenue (TTM)

$67.22K

Gross Profit (TTM)

$21.95K

EBITDA (TTM)

-$11.77M

Year Range

$3.13 - $22.15

Target Price

$12.00

Short %

2.61%

Short Ratio

6.65

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
ZIVO vs. ^GSPC
Popular comparisons:
ZIVO vs. ^GSPC

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ZIVO Bioscience, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025February
123.53%
9.31%
ZIVO (ZIVO Bioscience, Inc.)
Benchmark (^GSPC)

Returns By Period

ZIVO Bioscience, Inc. had a return of -11.63% year-to-date (YTD) and 131.71% in the last 12 months. Over the past 10 years, ZIVO Bioscience, Inc. had an annualized return of 44.82%, outperforming the S&P 500 benchmark which had an annualized return of 11.31%.


ZIVO

YTD

-11.63%

1M

2.70%

6M

123.53%

1Y

131.71%

5Y*

85.00%

10Y*

44.82%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of ZIVO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-7.91%-11.63%
2024579.90%-1.79%-3.28%1.94%0.76%-2.01%8.97%58.82%21.78%18.61%5.13%4.88%1,691.67%
202345.60%-9.20%-6.81%-4.55%-6.46%-12.00%-15.70%-11.76%-27.78%-65.38%-74.35%73.29%-92.00%
2022-3.14%27.70%9.30%-17.53%2.50%19.51%-7.67%3.61%-25.33%11.07%-15.76%-4.58%-12.89%
20210.00%3.33%-17.42%4.69%3,026.87%13.13%-26.16%-9.14%43.40%-21.71%-5.88%-14.58%1,813.33%
2020-9.70%0.67%-22.07%-6.07%0.18%-1.45%-0.37%1.85%7.55%25.53%-9.23%11.28%-9.09%
2019-19.23%-0.00%33.33%-22.00%-3.85%-3.52%-6.91%-7.42%-19.70%13.69%50.56%37.50%26.92%
20180.42%18.42%-12.89%-10.71%42.86%36.00%-30.94%25.64%8.47%-21.25%18.41%-12.87%37.42%
201712.63%-0.09%-23.29%3.66%-17.76%-14.16%6.67%-6.25%53.17%-18.39%60.00%-21.17%-0.42%
2016-11.30%56.86%-0.13%-8.26%-4.50%-7.29%-19.26%-4.39%9.78%63.64%33.33%-20.83%65.22%
2015-21.27%59.16%-20.91%-10.98%143.19%-26.25%-24.00%28.42%-34.43%0.00%-18.75%-11.54%-27.22%
2014-30.77%-0.81%-36.52%10.24%1.39%-15.89%-12.52%-7.01%0.38%-9.58%-16.10%-20.20%-79.74%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 99, ZIVO is among the top 1% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ZIVO is 9999
Overall Rank
The Sharpe Ratio Rank of ZIVO is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of ZIVO is 9898
Sortino Ratio Rank
The Omega Ratio Rank of ZIVO is 9898
Omega Ratio Rank
The Calmar Ratio Rank of ZIVO is 100100
Calmar Ratio Rank
The Martin Ratio Rank of ZIVO is 100100
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ZIVO Bioscience, Inc. (ZIVO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ZIVO, currently valued at 14.39, compared to the broader market-2.000.002.0014.391.74
The chart of Sortino ratio for ZIVO, currently valued at 5.37, compared to the broader market-4.00-2.000.002.004.006.005.372.35
The chart of Omega ratio for ZIVO, currently valued at 1.77, compared to the broader market0.501.001.502.001.771.32
The chart of Calmar ratio for ZIVO, currently valued at 26.93, compared to the broader market0.002.004.006.0026.932.61
The chart of Martin ratio for ZIVO, currently valued at 130.57, compared to the broader market0.0010.0020.0030.00130.5710.66
ZIVO
^GSPC

The current ZIVO Bioscience, Inc. Sharpe ratio is 14.39. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of ZIVO Bioscience, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.005.0010.0015.0020.00SeptemberOctoberNovemberDecember2025February
14.39
1.74
ZIVO (ZIVO Bioscience, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


ZIVO Bioscience, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-41.90%
0
ZIVO (ZIVO Bioscience, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ZIVO Bioscience, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ZIVO Bioscience, Inc. was 98.52%, occurring on Nov 28, 2023. The portfolio has not yet recovered.

The current ZIVO Bioscience, Inc. drawdown is 41.90%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.52%Sep 27, 2021545Nov 28, 2023
-92.08%Apr 25, 2013667Jan 14, 20161270May 28, 20211937
-46.26%Jun 11, 202169Sep 17, 20215Sep 24, 202174
-38.72%Sep 25, 201230Nov 16, 201223Dec 24, 201253
-29.77%Jan 9, 201336Mar 4, 201315Mar 25, 201351

Volatility

Volatility Chart

The current ZIVO Bioscience, Inc. volatility is 23.34%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
23.34%
3.07%
ZIVO (ZIVO Bioscience, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ZIVO Bioscience, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for ZIVO Bioscience, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab